ymrise has secured a major achievement in China for its SymSave® H technology. The China National Intellectual Property Administration (CNIPA) is upholding the validity of Chinese Patent 111631216 B (CN’216) for the technology behind the multifunctional, antioxidant, product protectant enhancer ingredient. This decision reinforces the uniqueness of the technology. It also strengthens the position of Symrise in the cosmetics and personal care market.
The CNIPA decision secures Symrise’s exclusive rights to utilize and commercialize SymSave® H technology in China. This enhances the patent’s value and strengthens Symrise’s competitive edge. With hydroxyacetophenone as its INCI, it helps extend product shelf life, reduce oxidation even for sensitive skin.
CNIPA’s decision follows a rigorous review process, including bilateral invalidation proceedings. This confirms that the SymSave® H technology meets China’s strict patent criteria, including novelty, inventiveness, and clear disclosure.
By promoting gentler, consumer-friendly formulations, SymSave® H supports cleaner labeling, effective product protection, and consistent quality. By working in synergy with other multifunctionals, it improves the performance of personal care formulations. “The confirmation of CN’216 highlights CNIPA’s commitment to a thorough and impartial review process,” noted Sven Siegel, Global Director Intellectual Properties at Symrise AG. “This ensures only patents with genuine merit are upheld.” The validation of CN’216 is expected to have a positive impact on Symrise AG, encouraging further innovation and investment in related technologies.